Spruce Biosciences (SPRB) Total Debt (2019 - 2026)
Spruce Biosciences (SPRB) posted quarterly Total Debt of $6.5 million for Q1 2026, up 380.59% year-over-year from $1.3 million in Q1 2025, and up 1099.26% quarter-over-quarter from $539000.0 in Q3 2025.
Spruce Biosciences (SPRB) Total Debt (2019 - 2026) Analysis & Trends
Spruce Biosciences (SPRB) has reported Total Debt for 8 consecutive years, with $6.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Debt rose 380.59% year-over-year to $6.5 million; the TTM figure through Mar 2026 stood at $6.5 million (up 380.59% YoY), while the FY2024 annual figure was $1.7 million, down 47.71% from the prior year.
- Total Debt improved to $6.5 million in Q1 2026 per SPRB's latest filing, from $539000.0 in the prior quarter.
- Across five years, Total Debt topped out at $6.5 million in Q1 2026 and bottomed at $539000.0 in Q3 2025.
- Historically, Total Debt has averaged $3.4 million across 5 years, with a median of $3.5 million in 2023.
- Annual changes were most pronounced in 2025 — Total Debt tumbled 74.88% — and 2026, when it jumped 380.59%.
- Spruce Biosciences' Total Debt stood at $4.9 million in 2022, then slumped by 32.07% to $3.3 million in 2023, then slumped by 47.71% to $1.7 million in 2024, then sank by 69.13% to $539000.0 in 2025, then surged by 1099.26% to $6.5 million in 2026.
- Business Quant data shows SPRB's Total Debt at $6.5 million in Q1 2026, $539000.0 in Q3 2025, and $943000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.34 Bn |
| 10 | Spruce Biosciences | 119.20 Mn | 119.20 Mn | - | 7.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.09 Mn |
| Mar 31, 2026 | 6.46 Mn |
| Sep 30, 2025 | 539,000.00 |
| Jun 30, 2025 | 943,000.00 |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 1.75 Mn |
| Sep 30, 2024 | 2.15 Mn |
| Jun 30, 2024 | 2.55 Mn |
| Mar 31, 2024 | 2.94 Mn |
| Dec 31, 2023 | 3.34 Mn |
| Sep 30, 2023 | 3.74 Mn |
| Jun 30, 2023 | 4.13 Mn |
| Mar 31, 2023 | 4.52 Mn |
| Dec 31, 2022 | 4.92 Mn |
| Sep 30, 2022 | 4.90 Mn |
| Jun 30, 2022 | 4.89 Mn |
| Mar 31, 2022 | 4.89 Mn |
| Dec 31, 2021 | 4.88 Mn |
| Sep 30, 2021 | 4.87 Mn |
| Jun 30, 2021 | 4.86 Mn |